🎥 Replay — 15ᵉ Café de l’IReSP : Prev-HPV

Value of the Information & Strength of the Argument

The video provides valuable insights into a real-world public health intervention, presenting both positive and null results. The argumentation is solid, based on a rigorous randomized controlled trial with objective outcome measures (vaccination coverage from national health data). The speakers clearly explain the methodology, including the co-construction process and the consideration of intervention dose. They also discuss limitations, such as low participation of parents and GPs, and the challenges of implementing school-based interventions. The presentation is balanced, acknowledging that the education intervention did not lead to behavior change despite improving knowledge and attitudes. The Q&A adds practical information on vaccination logistics and legal aspects. Overall, the value lies in its evidence-based approach and practical implications for public health policy.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high: the program is based on a phased research design, including a diagnostic phase and a randomized controlled trial. The use of objective data from the national health data system (SNDS) for vaccination coverage is a strength. The co-construction of interventions with stakeholders enhances relevance and feasibility. The sources cited are primarily the research program itself and its publications, though specific references are not detailed in the video. The title accurately reflects the content, as it is a replay of a research presentation. The video is produced by IReSP, a recognized public health research institute, adding credibility. However, the video does not provide detailed citations or links to publications, which limits the ability to verify specific claims. Overall, the rigor is commendable, but the lack of explicit source references is a minor weakness.

The title accurately reflects the content: a replay of the 15th IReSP Café focusing on the Prev-HPV research program.

8/10

The video presents results from a research program (Prev-HPV) with a rigorous methodology including randomized controlled trial, objective data from national health data system, and transparent discussion of limitations. The speakers are researchers from a recognized institution (IReSP, Inserm). The presentation is clear and well-structured, with a balanced view of findings.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction by Mélanie Sumonie, presenting the IReSP Café format and introducing the speakers.
• 01:00Nathalie Thilly introduces the Prev-HPV program and outlines the presentation plan.
• 03:00Context: description of the diagnostic phase (2019-2021) and the three interventions developed.
• 07:00Aurélie B. details the co-construction process with stakeholders and the iterative development of tools.
• 10:00Description of the education/motivation/mobilization intervention: online parent meetings, school sessions, serious game, videos.
• 13:00Description of the facilitation of access intervention: on-site vaccination days with mobile teams.
• 16:00Description of the GP training intervention and the shared decision-making tool.
• 19:00Results on vaccination coverage: facilitation of access significantly increases coverage, education has no significant effect.
• 22:00Results on knowledge, attitudes, and intentions: education improves knowledge and attitudes, but not behavior.
• 25:00Discussion: challenges of school-based interventions, importance of parental involvement, and implications for implementation.
• 28:00Q&A session: adherence rate (15%), legal aspects of vaccination by school nurses, and interdisciplinary collaboration.

• Prev-HPV project page on IReSP website — Mentioned as the source for all intervention tools and detailed information.

• Santé publique France - HPV vaccination data — Provides national data on HPV vaccination coverage, consistent with the program's findings.